TrialAddiction (Abingdon, England)2023

A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.

Ximena A Levander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.